secwatch.observer — SEC 8-K summary
======================================

Issuer:     Assertio Holdings, Inc. (ASRT)
CIK:        0001808665
Form:       8-K
Filed at:   2026-04-09T23:59:59+00:00
Accession:  0001104659-26-041236
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Assertio to be acquired by Garda for $18/share plus CVR; sells assets to Cosette for $35M
--------------------------------------------------------------------------------

- Garda Therapeutics to acquire Assertio via cash tender offer at $18.00 per share plus one CVR per share.
- Concurrently, Assertio sells its INDOCIN, SPRIX, and other product franchises to Cosette for $35M cash plus up to $35M in milestones.
- Equity investors commit $17M and Colbeck provides $87M debt financing; no financing condition for the offer.
- Closing conditions include minimum net cash of $115M; termination fee is $4.8M ($1.75M for qualified bidder).
- Company to launch note offer for its $40M 6.50% Convertible Notes due 2027 contingent on merger.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808665/000110465926041236/0001104659-26-041236-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808665/000110465926041236/tm2611405d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-041236

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer